SureTrader
Nadex Advertisement
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Blueprint Medicines Corporation (BPMC)

BPMC RSS Feed
Add BPMC Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 6/5/2016 12:43:36 PM - Followers: 6 - Board type: Free - Posts Today: 0

Blueprint Medicines is a patient-driven oncology company developing highly selective kinase inhibitors for genomically defined cancer subsets. Led by a management team and advisors with world-renowned expertise in cancer genomics, drug discovery and clinical oncology, Blueprint has developed a platform that combines genomics with a novel library of kinase inhibitors, enabling Blueprint to rapidly develop potent highly selective compounds against clear genomic driver targets.
BPMC
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SureTrader
BPMC News: Statement of Changes in Beneficial Ownership (4) 07/07/2017 04:39:02 PM
BPMC News: Statement of Changes in Beneficial Ownership (4) 07/07/2017 04:37:45 PM
BPMC News: Statement of Changes in Beneficial Ownership (4) 06/30/2017 06:21:33 PM
BPMC News: Statement of Changes in Beneficial Ownership (4) 06/30/2017 06:20:45 PM
BPMC News: Statement of Changes in Beneficial Ownership (4) 06/30/2017 06:20:16 PM